Pangea Bio
Chris Hayes is an experienced intellectual property lawyer with a background in genetics. Specializing in all aspects of IP law, Chris has held various roles in both law firms and pharmaceutical companies. With a commercial approach, Chris has worked as a barrister and partner in multiple firms before taking on positions as a Director and Member in different companies. Chris currently serves as the Chief Intellectual Property Officer at Pangea Botanica and as a Non-Executive Director at PsiClone Ltd, Neurone Ltd, and the Royal Society of Biology.
Pangea Bio
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use.